The increase in confirmed COVID-19 cases and SARS-CoV-2 variants calls for the development of safe and broad cross-protective vaccines. The RBD of the spike protein was considered to be a safe and effective candidate antigen. However, the low immunogenicity limited its application in vaccine development. Herein, we designed and obtained an RBD heptamer (mHla-RBD) based on a carrier protein-aided assembly strategy. The molecular weight of mHla-RBD is up to 450 kDa, approximately 10 times higher than that of the RBD monomer. When formulated with alum adjuvant, mHla-RBD immunization significantly increased the immunogenicity of RBD, as indicated by increased titers of RBD-specific antibodies, neutralizing antibodies, Th2 cellular immune response, and pseudovirus neutralization activity, when compared to RBD monomer. Furthermore, we confirmed that RBD-specific antibodies predominantly target conformational epitopes, which was approximately 200 times that targeting linear epitopes. Finally, a pseudovirus neutralization assay revealed that neutralizing antibodies induced by mHla-RBD against different SARS-CoV-2 variants were comparable to those against the wild-type virus and showed broad-spectrum neutralizing activity toward different SARS-CoV-2 variants. Our results demonstrated that mHla-RBD is a promising candidate antigen for development of SARS-CoV-2 vaccines and the mHla could serve as a universal carrier protein for antigen design.
【저자키워드】 COVID-19, SARS-CoV-2, Subunit vaccine, oligomerization, mHla-RBD, 【초록키워드】 neutralizing antibody, Vaccine development, immunogenicity, Vaccines, Neutralizing antibodies, Cellular immune response, Th2, SARS-CoV-2 variant, SARS-CoV-2 vaccines, immunization, SARS-CoV-2 vaccine, Spike protein, Antigen, Protein, Epitopes, Neutralizing activity, SARS-CoV-2 variants, pseudovirus, RBD, Pseudovirus neutralization assay, specific antibodies, conformational epitopes, COVID-19 cases, alum, Safe, carrier protein, neutralization activity, wild-type virus, monomer, RBD-specific antibodies, linear epitopes, confirmed COVID-19 case, alum adjuvant, molecular weight, effective, significantly increased, indicated, the spike protein, demonstrated, the RBD, conformational, increase in, comparable, kDa, cross-protective, RBD-specific antibody, 【제목키워드】 RBD, Improved, Against, the Spike,